Amphenol's interim report prints uniformly higher top line, operating income, net income, and diluted EPS for the three-month window

Bottom line

The headline takeaway from AMPHENOL CORP /DE/'s interim filing under 10-Q for period-ended-2026-03-31, identified by accession 0001104659-26-054128, is that every top-line and bottom-line measure on the three-month window moved in the same direction as the prior-year comparative, and each of those moves is one of growth rather than contraction. Specifically, Revenue from Contract with Customer, Excluding Assessed Tax printed at $7,620,100,000 in the three months ended March 31, 2026, higher than the $4,811,000,000 recorded in the three months ended March 31, 2025. Operating Income (Loss) followed the same pattern, moving from $1,024,800,000 in the three months ended March 31, 2025 to $1,831,800,000 in the three months ended March 31, 2026 and remaining in profit on both sides of the comparison. Net Income (Loss) Attributable to Parent likewise stepped up, climbing from $737,800,000 to $933,000,000, preserving its profit status across the two windows. Earnings Per Share, Diluted ended at $0.72 per diluted share in the current quarter against $0.58 per diluted share in the year-ago quarter, again a profit-to-profit comparison with the per-share figure running higher than its prior-year counterpart.

On reporting-period identity and source scope, the document is the interim report AMPHENOL CORP /DE/ filed under 10-Q for period-ended-2026-03-31, tied to the 0000820313 identifier and the 0001104659-26-054128 accession number, and trades under APH. The figures above are drawn from the Condensed Consolidated Statements of Income for the three-month window, prepared in conformity with U.S. generally accepted accounting principles as discussed in Note 1. The unaudited interim financial statements are intended to be read together with the audited consolidated statements in the Company's Annual Report referenced in Note 1, and management notes in Note 1 that the three-month results are not necessarily indicative of the full-year outcome.

Where the evidence does not speak, the analysis is silent. The filing offers no per-segment or per-geography split for the quarter on the measures catalogued here, so any sub-mix commentary would be unsupported. The filing evidence does not attribute this change to any single cause. Peer benchmarking is similarly out of scope for the filing evidence, so any cross-issuer commentary, including comparison with filings such as SMITH A O CORP (AOS) Reports Softer Revenue, Operating Income, Net Income, and Diluted EPS on Both the Quarter and Six-Month Year-to-Date Views in Form (Accession, would go beyond what this section's source window allows. The filing evidence contains no peer or industry comparison.

Financial performance

- Reader-facing analysis supported by the cited evidence follows this label.

Revenue from Contract with Customer, Excluding Assessed Tax reached $7,620,100,000 USD for the three months ended March 31, 2026, compared with $4,811,000,000 USD for the three months ended March 31, 2025. The filing authorizes a year-over-year direction of increase, so the top line moved higher against the prior-year quarter while remaining a positive figure on both sides of the comparison.

Operating Income (Loss) landed at $1,831,800,000 USD for the three-month reporting period the three months ended March 31, 2026, against $1,024,800,000 USD for the three months ended March 31, 2025. Both periods sit on the profit side of the ledger, with the authorized direction reading as an increase, and the authorized transition running profit to profit rather than crossing into a loss.

Net Income (Loss) Attributable to Parent was $933,000,000 USD for the three months ended March 31, 2026, versus $737,800,000 USD for the three months ended March 31, 2025. The authorized direction is an increase, and the authorized transition is again profit to profit, so the headline earnings line stepped up without changing sign versus the prior-year quarter.

Earnings Per Share, Diluted was $0.72 per diluted share USD/SHARES for the three months ended March 31, 2026 and $0.58 per diluted share USD/SHARES for the three months ended March 31, 2025. The authorized direction is an increase, with the prior comparative and the current period both sitting in profit territory.

Management's own commentary in the cited filing text does not narrate the drivers behind these moves. The narrative instead addresses near-term accounting and liquidity context: the Company is currently evaluating the impact of an ASU on its consolidated financial statements and disclosures and is also evaluating the potential impact of a separately cited ASU on its interim consolidated financial statements and disclosures. On the financing side, management confirms the Revolving Credit Facility matures in March of the cited year, that the Company and certain subsidiaries can borrow in various currencies at a spread tied to debt rating, and that any borrowings under that facility would be classified as Level 2 in the fair value hierarchy under Note 5. The narrative also discusses the U.S. Commercial Paper Program and the Euro Commercial Paper Program, the use of proceeds for general corporate purposes including acquisition funding, and the Board-level cap that limits the combined outstanding amount of USCP Notes, ECP Notes, any other commercial paper or similar programs, and outstanding amounts under the Revolving Credit Facility. Any outstanding Commercial Paper is classified as long-term debt, and its carrying value is treated as Level 2 in the fair value hierarchy under Note 5.

Analyst inference is intentionally narrow here because the filing evidence is silent on the cause of the year-over-year movements. The filing evidence does not attribute this change to any single cause.

Counter-evidence: the filing does not present segment-level detail for these dimensions, so The filing evidence does not disclose segment-level detail for this dimension. Peer or industry comparison data is not contained in the filing, so The filing evidence contains no peer or industry comparison.

Quarter-over-quarter comparison is not authorized for these dimensions in the filing evidence, so the prior-sequential-quarter relationship is left unspecified. Guidance commentary is similarly absent from the cited filing text, and forward-looking statements are not asserted here.

Operating drivers and segments

The condensed consolidated statements included in 10-Q for period-ended-2026-03-31 under accession 0001104659-26-054128 present Amphenol Corporation (APH, 0000820313) as a single consolidated reporting entity rather than as a set of separately disclosed operating segments. The three-month reporting period (the three months ended March 31, 2026) carries revenue of $7,620,100,000 and operating income of $1,831,800,000, both expressed as positive amounts, against a prior-year three-month comparative (the three months ended March 31, 2025) showing revenue of $4,811,000,000 and operating income of $1,024,800,000.

Under the reported comparisons registered for this filing, Revenue moved higher year over year and Operating Income moved higher year over year, with Operating Income retaining a profit in both windows. No segment-level revenue split, segment-level operating margin, or end-market breakdown is disclosed in the excerpts that this section can quote, so segment contribution to the consolidated movement cannot be reconstructed from the evidence on hand. Management frames the quarter primarily through three lenses that appear in the cited notes.

First, Note 1 confirms the basis of presentation, the inclusion of Amphenol and its subsidiaries, and the reliance on normal recurring adjustments; it cautions that the the three months ended March 31, 2026 results are not necessarily indicative of the full year and directs readers to the most recent Annual Report on the cited form for context. Second, Note 2 discusses new accounting pronouncements, including the disaggregation of income statement expenses ASU and the interim reporting improvements ASU, both described as under evaluation for their impact on consolidated financial statements and disclosures, with prospective application and an option for retrospective application noted.

S. Commercial Paper Program, and the fact that the Company issued and subsequently repaid all outstanding USCP Notes during the first quarter, with proceeds used for general corporate purposes and repayment funded with cash on hand. No management commentary in the excerpts attributes the consolidated revenue and operating income movement to specific end markets, geographies, customers, acquisitions, or pricing actions, so a directed causal story is not available from the filing text itself.

The filing evidence does not attribute this change to any single cause. - The filing does not disclose peer or industry benchmarking against which Amphenol's quarterly revenue and operating income movement could be sized, so any cross-company read on relative performance falls outside the filing evidence. The filing evidence contains no peer or industry comparison.

- The reference inventory surfaces only finance-statement notes and Part II items such as Item 1, Item 1A, Item 2, Item 3, Item 4, Item 5, and Item 6, together with fair-value hierarchy levels (Level 1, Level 2, Level 3) and additional debt and inventory notes (Note 3, Note 4, Note 5, Note 10, Note 11); none of those passages quoted in the text supplies a segment narrative. - Readers comparing Amphenol's higher-on-both-lines directional pattern to other recent interim filers may find the parallel framing in Costco Wholesale Posts Higher Revenue, Operating Income, Net Income, and Diluted EPS on Both the Quarter and the Eight-Month Year-to-Date Windows useful as a reference point for how a uniformly higher top line and operating line can appear together in a quarterly print, although the underlying businesses are not directly comparable.

Cash flow and capital

- Amphenol generated a higher level of Net Cash Provided by (Used in) Operating Activities in the three-month reporting period the three months ended March 31, 2026 compared with the prior-year comparative the three months ended March 31, 2025; both periods show a positive direction on this line, and the current quarter is the larger of the two. , higher on the dollar scale) of the two periods. - Net Cash Provided by (Used in) Financing Activities swung from a negative reading in the three months ended March 31, 2025 to a positive reading in the three months ended March 31, 2026, an authorized increase that flips the prior-period use into the current-period source.

- Payments to Acquire Property, Plant, and Equipment were larger in the three months ended March 31, 2026 than in the three months ended March 31, 2025; both periods show a positive cash outflow direction. - Payments of Ordinary Dividends, Common Stock were larger in the three months ended March 31, 2026 than in the three months ended March 31, 2025; both periods show a positive cash outflow direction. - Payments for Repurchase of Common Stock were smaller in the three months ended March 31, 2026 than in the three months ended March 31, 2025; both periods show a positive cash outflow direction, with the current quarter being the lower spend on buybacks.

- The combined signal is operating cash generation strengthened, investing outflows narrowed, and financing activity flipped from net user to net provider, while capital expenditure and dividend outflows each stepped up versus the prior year. - Buyback outflows moderated versus the prior year, consistent with the larger financing inflow being driven by net debt and credit-facility activity rather than by stock repurchases. - On the balance sheet at the balance sheet date of March 31, 2026, Cash and Cash Equivalents, at Carrying Value stood at $4,128,000,000 USD, while Accounts Payable, Current stood at $3,181,500,000 USD.

S. and Euro commercial paper programs; the carrying value of Commercial Paper is classified in the cited fair-value tier Level 2 under Note 5. - The narrative further describes Two Delayed Draw Term Loan facilities entered into in August of the prior year, with the three-year facility and a shorter-day facility each classified in the same fair-value tier Level 2 under Note 5, and states that proceeds from the prior-period Senior Notes together with draws on the Delayed Draw Term Loans and cash on hand were used to fund the cash consideration for the CommScope acquisition, as further described in Note 11.

- The relative weighting of capex, dividends, and buybacks in the three months ended March 31, 2026 suggests capital allocation tilted toward reinvestment and shareholder returns through dividends rather than repurchases, with acquisition-related debt structuring evident in the financing line. - The fixed fair-value classification of the Commercial Paper and Delayed Draw Term Loans in Level 2 under Note 5 indicates observable market inputs drove their carrying-value measurements. - The filing evidence does not attribute this change to any single cause.

- Readers comparing this filing with peer interim reports can place Amphenol's capital allocation alongside the patterns described in SMITH A O CORP (AOS) Reports Softer Revenue, Operating Income, Net Income, and Diluted EPS on Both the Quarter and Six-Month Year-to-Date Views in Form (Accession to gauge cross-sector capital allocation.

Peer and historical context

" Revenue from Contract with Customer, Excluding Assessed Tax, Operating Income (Loss), Net Income (Loss) Attributable to Parent, and Net Cash Provided by (Used in) Operating Activities all sit on the higher side of their respective prior-period comparatives, and each is a positive number rather than a loss or a cash outflow. That uniformity is the section's headline, and it is what frames any cross-period reading of 10-Q for period-ended-2026-03-31 under 0001104659-26-054128. - The pattern is internally consistent in a second way worth noting: the income-statement lines and the operating-cash line move in the same direction, with no sign that a stronger top line is being squeezed by cost pressure on the way to operating income, or that profitability is diverging from cash generation in this window.

The filing evidence does not attribute this change to any single cause. - A useful sanity check for any reader comparing periods is to weigh this report against the trajectory in adjacent peer filings, such as SMITH A O CORP (AOS) Reports Softer Revenue, Operating Income, Net Income, and Diluted EPS on Both the Quarter and Six-Month Year-to-Date Views in Form 10-Q the reporting period (Accession, where the four-line direction in that issuer's three-month view is the mirror image of what AMPHENOL CORP /DE/ prints here.

- A reader looking for broader sector context, however, will not find it inside this filing. The filing evidence contains no peer or industry comparison. The same limitation applies to the segment view: The filing evidence does not disclose segment-level detail for this dimension.

so any segment-level versus consolidated discussion has to be set aside for this section. - The historical comparison in this filing is strictly the two three-month periods shown side by side; nothing in the catalog authorizes a multi-year stack-up, a pre-pandemic anchor, or a sequential quarter-over-quarter read for the items in scope. Readers wanting a longer time series would need to pull it from prior 10-Q filings rather than from this report.

Scenario analysis

Under the central case, AMPHENOL CORP /DE/ carries the recent momentum from the three months ended March 31, 2026 into the next reporting window, with $7,620,100,000 building on the higher level set against $4,811,000,000 and $933,000,000 extending the higher profit print versus $737,800,000. Operational execution, order-book conversion, and stable end-market demand in the connector and cable-assembly franchises support this read, while the broader macro picture neither accelerates nor impairs the trajectory. Working capital and capital expenditure cadence are assumed to stay consistent with the disclosure cadence of the 10-Q for period-ended-2026-03-31 (accession 0001104659-26-054128, CIK 0000820313, ticker APH). In this branch, the Company's debt structure — addressed in Note 4 and Note 11 — remains manageable, covenant tests stay in compliance as of the March reference point, and fair-value instruments categorised under Level 1, Level 2, and Level 3 per Note 5 continue to be measured without valuation stress.

A constructive branch layers faster order growth, easing input cost pressure, and incremental synergy capture on top of the the three months ended March 31, 2026 baseline. Revenue scales beyond the $7,620,100,000 versus $4,811,000,000 step-up, and the higher net income recorded at $933,000,000 versus $737,800,000 compounds as operating leverage widens. Funding flexibility is reinforced by the existing Euro and U.S. Senior Notes architecture and the revolver capacity referenced under Level 2, leaving room for further bolt-on activity alongside organic investment. Cross-checks such as the SMITH A O CORP (AOS) Reports Softer Revenue, Operating Income, Net Income, and Diluted EPS on Both the Quarter and Six-Month Year-to-Date Views in Form (Accession coverage highlight how peer comparables can frame expectations, though The filing evidence contains no peer or industry comparison. the filing evidence itself offers no direct industry read on AMPHENOL CORP /DE/.

A cautious branch contemplates softer end-market demand, FX headwinds, or integration friction that compresses the spread between $7,620,100,000 and $4,811,000,000, and narrows the profit improvement between $933,000,000 and $737,800,000. Refinancing conditions for the Euro Issuer obligations, redemption economics on the U.S. and Euro Notes, and any tightening of covenant headroom could weigh on the balance-sheet posture described in Note 4, while Level 3 instruments could become more sensitive to unobservable inputs if liquidity thins. The filing evidence does not attribute this change to any single cause. Litigation or supply-chain developments flagged in Item 1, Item 1A, and the controls discussion in Item 4 could also draw incremental attention, and risk-factor language in Item 3 may need re-evaluation.

Risks and what to watch

- Reported facts: For the three months ended March 31, 2026, the company filed under 10-Q for period-ended-2026-03-31 (accession 0001104659-26-054128, CIK 0000820313, ticker APH) and reported Revenue from Contract with Customer, Excluding Assessed Tax of $7,620,100,000 USD, against a prior-year comparative of $4,811,000,000 USD for the three months ended March 31, 2025. Net Income (Loss) Attributable to Parent for the three months ended March 31, 2026 was $933,000,000 USD, against $737,800,000 USD for the three months ended March 31, 2025. Both the current quarter and the prior-year comparative remained profitable on a year-over-year basis. - Management explanations: The fair-value methodology section in Note 5 describes an exit-price framework that prefers market or observable inputs and falls back to hypothetical-transaction assumptions where inputs are unobservable, producing the Level 1 and Level 2 tiers for the debt instruments, pension plan assets, and acquisition-accounting items referenced through Note 4, Note 10, and Note 11. The Euro Issuer disclosures describe two existing unsecured senior note series in Europe (the Existing Euro Notes) and detail an optional redemption mechanic subject to certain terms and conditions, including paying (omitted) of the principal amount, plus accrued and unpaid interest, and, with certain exceptions, a make-whole premium. The Senior Notes are described as imposing certain obligations on the Company and prohibiting various actions unless it satisfies certain financial requirements. - Analyst inference: The combination of higher revenue, higher net income, higher financing- and operating-cash inflows, and higher ordinary-dividend payments, alongside lower investing outflows and lower share-repurchase payments, suggests a quarter in which capital allocation shifted toward dividend distributions and debt activity while buyback intensity moderated. Read alongside the citation network that ties fair-value disclosures to Note 4, Note 10, and Note 11, the fair-value sensitivity of debt and pension plan assets remains a structural input worth tracking, even though the specific quantitative impact is not stated in the quoted context. - Counter-evidence: The Level 3 fair-value tier — where significant inputs to the valuation model are unobservable — is referenced in the filing's quoted context, indicating that some measured items depend on assumptions rather than market prices. The Senior Notes covenants prohibit various actions unless certain financial requirements are met, which constrains the company's flexibility in periods of stress. The make-whole premium mechanic on the Existing Euro Notes raises the practical cost of early redemption. - Unknowns: The filing evidence does not attribute this change to any single cause. The filing evidence does not disclose segment-level detail for this dimension. The filing evidence contains no peer or industry comparison.

Readers comparing this filing against peers can cross-reference the quarter-over-quarter contour in CMS Energy Reports Softer Bottom Line Against Higher Contract Revenue in the reporting period 10-Q Filing, where the directional pattern differs from this issuer's higher-quarter outcome.

Next-period metrics to monitor include the next quarterly Revenue from Contract with Customer figure relative to the reported $7,620,100,000 USD baseline, the next Net Income figure relative to the $933,000,000 USD baseline, any movement in the Existing Euro Notes balance sheet position following the cited redemption mechanic, and any change in the fair-value classification between the Level 2 tier and the Level 3 tier for the cited debt and pension plan items.